Dr Pippa Corrie

BMBCh, PhD, FRCP

Clinical oncologist

Spoken languages

English

Special clinical interests in pancreatic cancer, biliary cancer, liver cancer, neuroendocrine tumours and melanoma.

Dr Corrie qualified in medicine at Oxford University, having already undertaken a PhD in anticancer drug development. She undertook specialist training in Medical Oncology in Birmingham before being appointed as Consultant at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke’s Hospital) in 1996 and subsequently Associate Lecturer at the University of Cambridge. Dr Corrie directed the chemotherapy service at Addenbrooke’s Hospital until 2014 and then focused her interests in leading clinical research.

She is NIHR Lead for Cancer Late Phase and International Trials and CRN Eastern Cancer Specialty Lead. Dr Corrie chaired the NCRI Skin Cancer Clinical Studies Group from 2012-2017 and is a member of the NCRI pancreatic cancer studies subgroup. Her specialist interests are melanoma and pancreaticobiliary cancers. Dr Corrie has published widely in these areas. She is the chief investigator of multiple academic and industry-sponsored national and international trials.

Treatments

  • Chemotherapy
  • Immunotherapy

Specialties

  • Melanoma
  • Pancreaticobiliary cancers
  • Neuroendocrine cancers

NHS Hospital / current post(s)

  • Consultant and Associate Lecturer in Medical Oncology, Addenbrooke’s Hospital Cambridge, and the University of Cambridge

Year qualified

1989

Research interests

  • Cancer clinical trials

Professional memberships

  • Fellow of the Royal College of Physicians (FRCP)
  • Member of National Cancer Research Institute Melanoma CSG
  • Member of the National Cancer Research Institute Pancreatic Cancer and HCC subgroups
  • Member of the British Association for Cancer Research
  • Member of the American Society of Clinical Oncology
  • Member of the European Organisation for Research and Treatment of Cancer – Melanoma Group
  • Member of the Medical Defence Union